First Time Loading...

Repligen Corp
NASDAQ:RGEN

Watchlist Manager
Repligen Corp Logo
Repligen Corp
NASDAQ:RGEN
Watchlist
Price: 157.06 USD -2.44% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. [ Read More ]

The intrinsic value of one RGEN stock under the Base Case scenario is 71.97 USD. Compared to the current market price of 157.06 USD, Repligen Corp is Overvalued by 54%.

Key Points:
RGEN Intrinsic Value
Base Case
71.97 USD
Overvaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Repligen Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RGEN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Repligen Corp

Provide an overview of the primary business activities
of Repligen Corp.

What unique competitive advantages
does Repligen Corp hold over its rivals?

What risks and challenges
does Repligen Corp face in the near future?

Has there been any significant insider trading activity
in Repligen Corp recently?

Summarize the latest earnings call
of Repligen Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Repligen Corp.

Provide P/S
for Repligen Corp.

Provide P/E
for Repligen Corp.

Provide P/OCF
for Repligen Corp.

Provide P/FCFE
for Repligen Corp.

Provide P/B
for Repligen Corp.

Provide EV/S
for Repligen Corp.

Provide EV/GP
for Repligen Corp.

Provide EV/EBITDA
for Repligen Corp.

Provide EV/EBIT
for Repligen Corp.

Provide EV/OCF
for Repligen Corp.

Provide EV/FCFF
for Repligen Corp.

Provide EV/IC
for Repligen Corp.

Show me price targets
for Repligen Corp made by professional analysts.

What are the Revenue projections
for Repligen Corp?

How accurate were the past Revenue estimates
for Repligen Corp?

What are the Net Income projections
for Repligen Corp?

How accurate were the past Net Income estimates
for Repligen Corp?

What are the EPS projections
for Repligen Corp?

How accurate were the past EPS estimates
for Repligen Corp?

What are the EBIT projections
for Repligen Corp?

How accurate were the past EBIT estimates
for Repligen Corp?

Compare the revenue forecasts
for Repligen Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Repligen Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Repligen Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Repligen Corp compared to its peers.

Compare the P/E ratios
of Repligen Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Repligen Corp with its peers.

Analyze the financial leverage
of Repligen Corp compared to its main competitors.

Show all profitability ratios
for Repligen Corp.

Provide ROE
for Repligen Corp.

Provide ROA
for Repligen Corp.

Provide ROIC
for Repligen Corp.

Provide ROCE
for Repligen Corp.

Provide Gross Margin
for Repligen Corp.

Provide Operating Margin
for Repligen Corp.

Provide Net Margin
for Repligen Corp.

Provide FCF Margin
for Repligen Corp.

Show all solvency ratios
for Repligen Corp.

Provide D/E Ratio
for Repligen Corp.

Provide D/A Ratio
for Repligen Corp.

Provide Interest Coverage Ratio
for Repligen Corp.

Provide Altman Z-Score Ratio
for Repligen Corp.

Provide Quick Ratio
for Repligen Corp.

Provide Current Ratio
for Repligen Corp.

Provide Cash Ratio
for Repligen Corp.

What is the historical Revenue growth
over the last 5 years for Repligen Corp?

What is the historical Net Income growth
over the last 5 years for Repligen Corp?

What is the current Free Cash Flow
of Repligen Corp?

Financials

Balance Sheet Decomposition
Repligen Corp

Current Assets 1.1B
Cash & Short-Term Investments 751.3m
Receivables 124.2m
Other Current Assets 235.6m
Non-Current Assets 1.7B
PP&E 323m
Intangibles 1.4B
Other Non-Current Assets 2.8m
Current Liabilities 158.2m
Accounts Payable 19.6m
Accrued Liabilities 39.1m
Other Current Liabilities 99.5m
Non-Current Liabilities 695m
Long-Term Debt 510.1m
Other Non-Current Liabilities 184.9m
Efficiency

Earnings Waterfall
Repligen Corp

Revenue
638.8m USD
Cost of Revenue
-323.5m USD
Gross Profit
315.2m USD
Operating Expenses
-228.5m USD
Operating Income
86.8m USD
Other Expenses
-45.2m USD
Net Income
41.6m USD

Free Cash Flow Analysis
Repligen Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

RGEN Profitability Score
Profitability Due Diligence

Repligen Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive Operating Income
54/100
Profitability
Score

Repligen Corp's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

RGEN Solvency Score
Solvency Due Diligence

Repligen Corp's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
91/100
Solvency
Score

Repligen Corp's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RGEN Price Targets Summary
Repligen Corp

Wall Street analysts forecast RGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RGEN is 208.71 USD with a low forecast of 161.6 USD and a high forecast of 236.25 USD.

Lowest
Price Target
161.6 USD
3% Upside
Average
Price Target
208.71 USD
33% Upside
Highest
Price Target
236.25 USD
50% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

RGEN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

RGEN Price
Repligen Corp

1M 1M
-21%
6M 6M
+7%
1Y 1Y
-8%
3Y 3Y
-26%
5Y 5Y
+187%
10Y 10Y
+903%
Annual Price Range
157.06
52w Low
114.17
52w High
208.42
Price Metrics
Average Annual Return 43.18%
Standard Deviation of Annual Returns 60.36%
Max Drawdown -65%
Shares Statistics
Market Capitalization 8.8B USD
Shares Outstanding 55 838 500
Percentage of Shares Shorted 10%

RGEN Return Decomposition
Main factors of price return

What is price return decomposition?

RGEN News

Other Videos

Company Profile

Repligen Corp Logo
Repligen Corp

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

8.8B USD

Dividend Yield

0%

Description

Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The company is headquartered in Waltham, Massachusetts and currently employs 1,852 full-time employees. The firm's bioprocessing business consist of four franchises, filtration; chromatography; process analytics; and proteins. The Filtration products are used in process development and process scale production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all monoclonal antibody (mAb) based drugs on the market.

Contact

MASSACHUSETTS
Waltham
41 Seyon St Bldg 1 Ste 100
+17814499560.0
https://www.repligen.com/

IPO

1986-04-29

Employees

1 852

Officers

CEO & Director
Mr. Anthony J. Hunt
Chief Operating Officer
Mr. James R. Bylund
Senior Vice President of Filtration & Chromatography
Ms. Christine Gebski
Senior Vice President of Research & Development
Mr. Ralf Kuriyel
President & Chief Commercial Officer
Mr. Olivier Loeillot
Chief Financial Officer
Mr. Jason K. Garland
Show More
Chief Information Officer
Mr. Keith Lee Robinson
Global Head of Investor Relations
Ms. Sondra S. Newman
General Counsel
Ms. Kimberly A. Cornwell
Senior Vice President of Marketing
Dr. Jaime M. Humara Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one RGEN stock?

The intrinsic value of one RGEN stock under the Base Case scenario is 71.97 USD.

Is RGEN stock undervalued or overvalued?

Compared to the current market price of 157.06 USD, Repligen Corp is Overvalued by 54%.